| Ranking | Registration number | Name | Petitioner | Candidate | Targeted support (in thousands CZK) |
| 1. | NU22-E-138 | Significance of specific T cell response after SARS-CoV2 vaccination for immunocompromised leukemia patients | RNDr. Šárka Němečková, DrSc. | Department of Hematology and Blood Transfusion | 4 538 |
| 2. | NU22-E-109 | SARS-CoV-2 N antigen in peripheral blood and risk factors for progression of COVID-19 to severe clinical disease | MUDr. Petr Hubáček, Ph.D. | University Hospital in Motol | 3 679 |
| 3. | NU22-E-152 | Prevention of complications in patients after COVID-19 disease - immune rehabilitation options | doc. MUDr. Eva Závadová, Ph.D. | General University Hospital in Prague | 8 041* |
* For the marked projects, a cost reduction has been proposed by the panels and the Scientific Council AZV , the amount of earmarked support is before the reduction and will be reduced after consultation with the applicant.